Annual Shareholders Equity
$554.20 M
+$86.75 M+18.56%
December 31, 2023
Summary
- As of February 26, 2025, SNDX annual stockholders equity is $554.20 million, with the most recent change of +$86.75 million (+18.56%) on December 31, 2023.
- During the last 3 years, SNDX annual shareholders equity has risen by +$302.01 million (+119.76%).
- SNDX annual shareholders equity is now at all-time high.
Performance
SNDX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$366.43 M
-$67.91 M-15.63%
September 30, 2024
Summary
- As of February 26, 2025, SNDX quarterly stockholders equity is $366.43 million, with the most recent change of -$67.91 million (-15.63%) on September 30, 2024.
- Over the past year, SNDX quarterly shareholders equity has increased by +$7.25 million (+2.02%).
- SNDX quarterly shareholders equity is now -33.88% below its all-time high of $554.20 million, reached on December 31, 2023.
Performance
SNDX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SNDX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | +2.0% |
| 3 y3 years | +119.8% | -2.2% |
| 5 y5 years | +944.7% | -2.2% |
SNDX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.7% | -33.9% | +8.4% |
| 5 y | 5-year | at high | +1653.8% | -33.9% | +1059.6% |
| alltime | all time | at high | +1992.2% | -33.9% | +6510.6% |
Syndax Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $366.43 M(-15.6%) |
| Jun 2024 | - | $434.34 M(-11.7%) |
| Mar 2024 | - | $491.89 M(-11.2%) |
| Dec 2023 | $554.20 M(+18.6%) | $554.20 M(+54.3%) |
| Sep 2023 | - | $359.19 M(-10.2%) |
| Jun 2023 | - | $400.04 M(-8.1%) |
| Mar 2023 | - | $435.50 M(-6.8%) |
| Dec 2022 | $467.45 M(+14.5%) | $467.45 M(+38.3%) |
| Sep 2022 | - | $338.10 M(-6.6%) |
| Jun 2022 | - | $361.94 M(-3.4%) |
| Mar 2022 | - | $374.55 M(-8.3%) |
| Dec 2021 | $408.37 M(+61.9%) | $408.37 M(+105.2%) |
| Sep 2021 | - | $199.00 M(-7.3%) |
| Jun 2021 | - | $214.56 M(-6.0%) |
| Mar 2021 | - | $228.21 M(-9.5%) |
| Dec 2020 | $252.19 M(+698.1%) | $252.19 M(+91.1%) |
| Sep 2020 | - | $131.98 M(-10.6%) |
| Jun 2020 | - | $147.65 M(+175.9%) |
| Mar 2020 | - | $53.51 M(+69.3%) |
| Dec 2019 | $31.60 M | $31.60 M(-28.3%) |
| Sep 2019 | - | $44.04 M(-20.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $55.27 M(-19.5%) |
| Mar 2019 | - | $68.63 M(+29.4%) |
| Dec 2018 | $53.05 M(-49.1%) | $53.05 M(-17.5%) |
| Sep 2018 | - | $64.27 M(-8.6%) |
| Jun 2018 | - | $70.35 M(-19.1%) |
| Mar 2018 | - | $86.95 M(-16.6%) |
| Dec 2017 | $104.32 M(+24.0%) | $104.32 M(+7.9%) |
| Sep 2017 | - | $96.71 M(-11.5%) |
| Jun 2017 | - | $109.34 M(+50.6%) |
| Mar 2017 | - | $72.61 M(-13.7%) |
| Dec 2016 | $84.14 M(+26.1%) | $84.14 M(-10.3%) |
| Sep 2016 | - | $93.83 M(-11.7%) |
| Jun 2016 | - | $106.24 M(-6.7%) |
| Mar 2016 | - | $113.85 M(+70.7%) |
| Dec 2015 | $66.70 M(-1266.9%) | $66.70 M(-5.7%) |
| Sep 2015 | - | $70.76 M(-1337.9%) |
| Dec 2014 | -$5.72 M(-148.2%) | -$5.72 M(+121.7%) |
| Sep 2014 | - | -$2.58 M(-159.8%) |
| Jun 2014 | - | $4.31 M(-48.9%) |
| Mar 2014 | - | $8.43 M(-28.8%) |
| Dec 2013 | $11.85 M(-140.5%) | $11.85 M |
| Dec 2012 | -$29.29 M | - |
FAQ
- What is Syndax Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals annual shareholders equity year-on-year change?
- What is Syndax Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Syndax Pharmaceuticals?
- What is Syndax Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Syndax Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of SNDX is $554.20 M
What is the all time high annual shareholders equity for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high annual stockholders equity is $554.20 M
What is Syndax Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, SNDX annual stockholders equity has changed by +$86.75 M (+18.56%)
What is Syndax Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of SNDX is $366.43 M
What is the all time high quarterly shareholders equity for Syndax Pharmaceuticals?
Syndax Pharmaceuticals all-time high quarterly stockholders equity is $554.20 M
What is Syndax Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, SNDX quarterly stockholders equity has changed by +$7.25 M (+2.02%)